Toxicity Studies of Fluorouracil Used With Adrenalectomy in Breast Cancer

Anthony J. Piro, MD; Richard E. Wilson, MD; Thomas C. Hall, MD; Menelaos A. Aliapoulios, MD; Hans B. Nevinny, MD; Francis D. Moore, MD
Arch Surg. 1972;105(1):95-99. doi:10.1001/archsurg.1972.04180070093020.
Text Size: A A A
Published online

Seventy-eight patients with advanced breast cancer were given fluorouracil by a slow infusion induction course starting in the immediate postoperative period after adrenalectomy, followed by direct weekly maintenance injections. By this method, fluorouracil was effective and well tolerated, with no greater toxicity than that from drug similarly administered in combination with prednisone to 27 nonadrenalectomized patients and to 21 patients given drug alone. There were no drug deaths in adrenalectomized patients; the incidence of adrenal insufficiency was not increased; and a greater corticoid replacement requirement was not seen. Greater hematologic and gastrointestinal toxicity as well as two toxic deaths were seen in patients given prednisone and fluorouracil. Drug dose, frequency of bony and liver metastases, concomitant irradiation, and previous myelosuppressive therapy did not contribute to this difference; older patients and advanced visceral disease appeared to be the major influencing factors.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.